Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjan.2012.06.001
Brazilian Journal of Anesthesiology
Scientific Article

Estudo comparativo entre bupivacaína (S75-R25) e ropivacaína para avaliar a segurança cardiovascular em bloqueio do plexo braquial

Comparative study related to cardiovascular safety between bupivacaine (S75-R25) and ropivacaine in brachial plexus block

Adilson Hamaji; Marcelo Rosa de Rezende; Rames Mattar Jr; Joaquim Edson Vieira; José Otávio Costa Auler Jr

Downloads: 0
Views: 654

Resumo

JUSTIFICATIVA E OBJETIVOS: Bupivacaína é o fármaco de escolha para anestesia regional por causa da eficácia, longa duração e do bloqueio motor menos intenso. Bupivacaína (S75-R25) é uma mistura de isômeros ópticos que contém 75% de levobupivacaína (S-) e 25% de dextrobupivacaína (R+) e foi criada por uma companhia farmacêutica brasileira. Este estudo comparou a eficácia e segurança de bupivacaína S75-R25 com vasoconstritor e ropivacaína para o sistema cardiovascular em bloqueio do plexo braquial. MÉTODOS: Pacientes foram randomizados para receber bloqueio do plexo braquial com bupivacaína S75-R25 (Grupo B) com epinefrina 1:200.000 ou ropivacaína (Grupo R), ambos os fármacos a 0,50%, em 30 mL ECG contínuo (Holter) foi registrado durante todo o procedimento, bem como a escala de força de Lovett, além de monitoramento (frequência cardíaca, oximetria de pulso e pressão arterial não invasiva). A incidência de eventos adversos foi comparada com os testes do qui-quadrado ou exato de Fisher. RESULTADOS: Quarenta e quatro pacientes foram estudados. Não houve diferença significativa em relação à idade, peso, altura, gênero e tempo cirúrgico. Não houve diferença entre arritmias supraventriculares antes ou depois do bloqueio do plexo braquial, independentemente do anestésico local escolhido. A perda de sensibilidade foi mais rápida no Grupo B (23,1 ± 11,7 min) em comparação com o Grupo R (26,8 ± 11,5 min), embora não significativa (p = 0,205, teste t de Student). Houve uma redução da frequência cardíaca, observada durante a monitoração contínua de 24 horas (Holter). CONCLUSÃO: Este estudo demonstrou eficácia semelhante entre bupivacaína S75-R25 e ropivacaína para bloqueio do plexo braquial, com incidências semelhantes de arritmias supraventriculares.

Palavras-chave

ANESTÉSICOS, Local, bupivacaína (S75-R25), ropivacaína, FARMACOLOGIA, Estereoisomerismo, eletrocardiografia ambulatorial, TÉCNICA ANESTÉSICA, Regional, plexo braquial

Abstract

BACKGROUND AND OBJECTIVES: Bupivacaine is a first choice for regional anesthesia considering its effectiveness, long duration and less motor blockade. Bupivacaine (S75-R25) is a mixture of optical isomers containing 75% levobupivacaine (S-) and 25% dextrobupivacaine (R+) created by a Brazilian pharmaceutical company. This investigation compared cardiac safety and efficacy of bupivacaine S75-R25 with vasoconstrictor and ropivacaine for brachial plexus blockade. METHODS: Patients were randomized to receive brachial plexus anesthesia with either bupivacaine S75-R25 with epinephrine 1:200,000 (bupi) or ropivacaine (ropi), both at 0.50%, in 30 mL solution. We registered a continuous Holter ECG throughout the procedure, as well as the Lovett scale of force in addition to monitoring (heart rate, pulse oximetry and non-invasive blood pressure). The incidence of adverse events was compared with the chi-square or Fisher test. RESULTS: We allocated forty-four patients into two groups. They did not show any difference related to age, weight or height, gender, as well as for surgical duration. Supraventricular arrhythmias were not different before or after the plexus blockade, independent of the local anesthetic chosen. Loss of sensitivity was faster for the bupivacaine group (23.1 ± 11.7 min) compared to the ropivacaine one (26.8 ± 11.5 min), though not significant (p = 0.205, Student t). There was a reduction in the cardiac rate, observed during the twenty-four-hour Holter monitoring. CONCLUSIONS: This study showed similar efficacy between bupivacaine S75-R25 for brachial plexus blockade and ropivacaine, with similar incidences of supraventricular arrhythmias.

Keywords

Amides, ropivacaine, Anesthesia, Conduction, Brachial Plexus, Bupivacaine, Electrocardiography, Ambulatory, Stereoisomerism

References

Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51:285-286.

Casati A, Chelly JE, Cerchierini E. Clinical properties of levobupivacaine or racemic bupivacaine for sciatic nerve block. J Clin Anesth. 2002;14(2):111-114.

Santorsola R, Casati A, Cerchierini E, Moizo E, Fanelli G. Levobupivacaine for peripheral blocks of the lower limb: a clinical comparison with bupivacaine and ropivacaine. Minerva Anestesiol.. 2001;67(9^s1):33-6.

Glaser C, Marhofer P, Zimpfer G. Levo-bupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth Analg. 2002;94(1):194-198.

Alley EA, Kopacz DJ, McDonald SB, Liu SS. Hyperbaric spinal levobupivacaine: a comparison to racemic bupivacaine in volunteers. Anesth Analg. 2002;94(1):188-193.

Casati A, Moizo E, Marchetti C, Vinciguerra F. A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth Analg. 2004;99(5):1387-1392.

Peduto VA, Baroncini S, Montanini S. A prospective, randomized, double blind comparison of epidural levobupivacaine 0.5% with epi-dural ropivacaine 0.75% for lower limb procedures. Eur J Anaesthesiol. 2003;20(12):979-983.

Casati A, Santorsola R, Aldegheri G. Intraoperative epidural anesthesia and postoperative analgesia with levobupivacaine for major orthopedic surgery: a doubleblind, randomized comparison of racemic bupivacaine and ropivacaine. J Clin Anesth. 2003;15(2):126-131.

Casati A, Borghi B, Fanelli G. Interscalene brachial plexus anesthesia and analgesia for open shoulder surgery: a randomized, double-blinded comparison between levobupivacaine and ropivacaine. Anesth Analg. 2003;96(1):253-259.

Casati A, Borghi B, Fanelli G. A double-blinded, randomized comparison of either 0.5% levobupivacaine or 0.5% ropivacaine for sciatic nerve block. Anesth Analg. 2002;94(4):987-990.

Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf.. 2002;25(3):153-163.

Casati A, Santorsola R, Cerchierini E, Moizo E. Ropivacaine. Minerva Anestesiol.. 2001;67(9^s1):15-19.

Morrison SG, Dominguez JJ, Frascarolo P, Reiz S. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg. 2000;90(6):1308-1314.

Chang DH, Ladd LA, Copeland S, Iglesias MA, Plummer JL, Mather LE. Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol. 2001;132(3):649-658.

Mazoit JX, Decaux A, Bouaziz H, Edouard A. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology. 2000;93(3):784-792.

Ohmura S, Kawada M, Ohta T, Yamamoto K, Kobayashi T. Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats. Anesth Analg. 2001;93(3):743-748.

Marganella C, Bruno V, Matrisciano F, Reale C, Nicoletti F, Melchiorri D. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice. Eur J Pharmacol. 2005;518(2-3):111-115.

Santos AC, DeArmas PI. Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology. 2001;95(5):1256-1264.

Aberg G. Toxicological and local anesthetic effects of optically active isomers of two local anesthetic compounds. Acta Pharmacol Toxicol. 1972;31:273-286.

Lee-Soon S, Wang GK, Concus A. Stereoselective inhibition of neuronal sodium channels by local anesthetics. Anesthesiology. 1992;77:324-325.

Delfino J, Vale NB. Bupivacaína levógira a 0,5% pura versus mistura enantiomérica de bupivacaína (S75-R25) a 0,5% em anestesia peridural para cirurgia de varizes. Rev Bras Anestesiol. 2001;51:474-482.

Tanaka PP, Souza RO, Salvalaggio MFO, Tanaka MAA. Estudo comparativo entre a bupivacaína a 0,5% e a mistura enantiomérica de bupivacaína (S75-R25) em anestesia peridural em pacientes submetidos a cirurgia ortopédica de membros inferiores. Rev Bras Anestesiol. 2003;53:331-337.

Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analogue ratings in analgesic studies. Clin Pharmachol Ther. 1985;38:16-23.

Breivick EK, Björnsson GA, Skovlund E. A comparison of pain rating scales by sampling from clinical trial data. Clin J Pain. 2000;16:22-28.

Borgeat A, Ekatodramis G, Blumenthal S. Interscalene brachial plexus anesthesia with ropivacaine 5mg/mL and bupivacaine 5mg/mL: effects on electrocardiogram. Reg Anesth Pain Med. 2004;29(6):557-563.

Huschak G, Rüffert H, Wehner M. Pharmacokinetics and clinical toxicity of prilocaine and ropivacaine following combined drug administration in brachial plexus anesthesia. Int J Clin Pharmacol Ther. 2009;47(12):733-743.

Pedro JR, Mathias LA, Gozzani JL, Pedro FS, Rittes JC. Supraclavicular brachial plexus block: a comparative clinical study between bupivacaine and levobupivacaine. Rev Bras Anestesiol. 2009;59(6):665-673.

D'Ambrosio A, De Negri P, Damato A, Cavalluzzo A, Borghi B. S(-) bupivacaine (levobupivacaine) in peripheral blocks: preliminary results. Minerva Anestesiol.. 2001;67(9^s1):37-43.

Liisanantti O, Luukkonen J, Rosenberg PH. High-dose bupivacaine, levobupivacaine and ropivacaine in axillary brachial plexus block. Acta Anaesthesiol Scand. 2004;48(5):601-606.

Kam PC, Kavanagh R, Yoong FF. The arterial tourniquet: pathophysiological consequences and anaesthetic implications. Anaesthesia. 2001;56(6):534-545.

Gielen MJ, Stienstra R. Tourniquet hypertension and its prevention: a review. Reg Anesth. 1991;16(4):191-194.

Cline E, Franz D, Polley RD, Maye J, Burkard J, Pellegrini J. Analgesia and effectiveness of levobupivacaine compared with ropivacaine in patients undergoing an axillary brachial plexus block. AANA J. 2004;72(5):339-345.

5dd4008b0e8825fe19c63493 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections